Analytics Command Center
AI-powered insights • Real-time analysis • Predictive intelligence
Total Plan Spend
$0
4.5%vs PY
Current PMPM
$0
3.2%vs PY
Active Members
0
3.1%vs PY
Stop-Loss Utilization
0%
20%vs PY
PMPM Trend & Forecast
Actual vs Budget with AI Projections
ActualBudgetProjected
Stop-Loss Status
Aggregate Utilization
78%Utilized
Specific (any member)
85%
Aggregate
42%
3 members at breach risk
Cost Distribution
Click segments to drill down
AI Insights
Stop-Loss Breach Imminent
2 hours agoMember M-4521 projected to exceed $275K specific deductible within 45 days based on current trajectory.
$45K potential94% confidence
GLP-1 Spend Acceleration
6 hours agoOzempic/Wegovy utilization up 89% YoY. 23 new starts in Q4. Projected $312K annual impact.
$156K potential91% confidence
Generic Substitution Opportunity
1 day agoAI identified $127K in potential savings through therapeutic alternatives for 8 high-cost medications.
$127K potential88% confidence
Care Management ROI
2 days agoDiabetes management program showing 4.2x ROI. Hospital admits down 23% for enrolled members.
$234K potential96% confidence
High-Cost Members
AI risk-scored with intervention recommendations
| Member ID | Risk Score | Primary Condition | YTD Claims | Projected | Trend | Intervention | Action |
|---|---|---|---|---|---|---|---|
| M-4521 | 94 | Hemophilia A | $249K | $312K | Care Management | ||
| M-7832 | 87 | Cancer - Breast | $189K | $245K | Oncology Review | ||
| M-2156 | 82 | Multiple Sclerosis | $157K | $198K | Specialty Pharmacy | ||
| M-9443 | 78 | ESRD | $142K | $175K | Transplant Eval | ||
| M-3287 | 75 | CHF | $129K | $158K | Remote Monitoring |